1.
Malivindi R, De Rose D, Santoro M, Gervasi S, Rago V, Aquila S. Follicle-stimulating hormone receptor (FSHR) a promising novel target for cancer diagnosis in seminoma and embryonal carcinoma. Ital J Anat Embryol [Internet]. 2017 Oct. 6 [cited 2024 Dec. 21];122(1):128. Available from: https://oajournals.fupress.net/index.php/ijae/article/view/1947